Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Living Without a Pulse: The Vascular Implications of Continuous-Flow Left Ventricular Assist Devices.

Purohit SN, Cornwell WK 3rd, Pal JD, Lindenfeld J, Ambardekar AV.

Circ Heart Fail. 2018 Jun;11(6):e004670. doi: 10.1161/CIRCHEARTFAILURE.117.004670.

PMID:
29903893
2.

Coronary Artery Remodeling and Fibrosis With Continuous-Flow Left Ventricular Assist Device Support.

Ambardekar AV, Weiser-Evans MCM, Li M, Purohit SN, Aftab M, Reece TB, Moulton KS.

Circ Heart Fail. 2018 May;11(5):e004491. doi: 10.1161/CIRCHEARTFAILURE.117.004491.

PMID:
29724722
3.

PTEN deficiency promotes pathological vascular remodeling of human coronary arteries.

Moulton KS, Li M, Strand K, Burgett S, McClatchey P, Tucker R, Furgeson SB, Lu S, Kirkpatrick B, Cleveland JC, Nemenoff RA, Ambardekar AV, Weiser-Evans MC.

JCI Insight. 2018 Feb 22;3(4). pii: 97228. doi: 10.1172/jci.insight.97228. [Epub ahead of print]

4.

Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism.

Jeong MY, Lin YH, Wennersten SA, Demos-Davies KM, Cavasin MA, Mahaffey JH, Monzani V, Saripalli C, Mascagni P, Reece TB, Ambardekar AV, Granzier HL, Dinarello CA, McKinsey TA.

Sci Transl Med. 2018 Feb 7;10(427). pii: eaao0144. doi: 10.1126/scitranslmed.aao0144.

5.

Pediatric Heart Transplantation: Transitioning to Adult Care (TRANSIT): Baseline Findings.

Grady KL, Hof KV, Andrei AC, Shankel T, Chinnock R, Miyamoto S, Ambardekar AV, Anderson A, Addonizio L, Latif F, Lefkowitz D, Goldberg L, Hollander SA, Pham M, Weissberg-Benchell J, Cool N, Yancy C, Pahl E.

Pediatr Cardiol. 2018 Feb;39(2):354-364. doi: 10.1007/s00246-017-1763-x. Epub 2017 Nov 3.

PMID:
29098353
6.

Defining Ambulatory Advanced Heart Failure: MedaMACS and Beyond.

Stewart GC, Ambardekar AV, Kittleson MM.

Curr Heart Fail Rep. 2017 Dec;14(6):498-506. doi: 10.1007/s11897-017-0363-7. Review.

PMID:
28952014
7.

Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart Failure.

Ambardekar AV, Thibodeau JT, DeVore AD, Kittleson MM, Forde-McLean RC, Palardy M, Mountis MM, Cadaret L, Teuteberg JJ, Pamboukian SV, Xie R, Stevenson LW, Stewart GC.

JACC Heart Fail. 2017 Sep;5(9):663-671. doi: 10.1016/j.jchf.2017.04.009. Epub 2017 Aug 16.

PMID:
28822745
8.

Perioperative Management of Cardiac Transplant Recipients Undergoing Noncardiac Surgery: Unique Challenges Created by Advancements in Care.

Jurgens PT, Aquilante CL, Page RL 2nd, Ambardekar AV.

Semin Cardiothorac Vasc Anesth. 2017 Sep;21(3):235-244. doi: 10.1177/1089253217706164. Epub 2017 May 3. Review.

PMID:
28466755
9.

Medication regimen complexity in ambulatory older adults with heart failure.

Cobretti MR, Page RL 2nd, Linnebur SA, Deininger KM, Ambardekar AV, Lindenfeld J, Aquilante CL.

Clin Interv Aging. 2017 Apr 12;12:679-686. doi: 10.2147/CIA.S130832. eCollection 2017.

10.

Dynamic Changes in Aortic Vascular Stiffness in Patients Bridged to Transplant With Continuous-Flow Left Ventricular Assist Devices.

Patel AC, Dodson RB, Cornwell WK 3rd, Hunter KS, Cleveland JC Jr, Brieke A, Lindenfeld J, Ambardekar AV.

JACC Heart Fail. 2017 Jun;5(6):449-459. doi: 10.1016/j.jchf.2016.12.009. Epub 2017 Mar 8.

11.

Imaging cardiac SCN5A using the novel F-18 radiotracer radiocaine.

Hooker JM, Strebl MG, Schroeder FA, Wey HY, Ambardekar AV, McKinsey TA, Schoenberger M.

Sci Rep. 2017 Feb 16;7:42136. doi: 10.1038/srep42136.

12.

Chronic Norovirus Infections in Cardiac Transplant Patients.

Jurgens PT, Allen LA, Ambardekar AV, McIlvennan CK.

Prog Transplant. 2017 Mar;27(1):69-72. doi: 10.1177/1526924816679843. Epub 2016 Nov 23.

PMID:
27881814
13.

Signal-Dependent Recruitment of BRD4 to Cardiomyocyte Super-Enhancers Is Suppressed by a MicroRNA.

Stratton MS, Lin CY, Anand P, Tatman PD, Ferguson BS, Wickers ST, Ambardekar AV, Sucharov CC, Bradner JE, Haldar SM, McKinsey TA.

Cell Rep. 2016 Aug 2;16(5):1366-1378. doi: 10.1016/j.celrep.2016.06.074. Epub 2016 Jul 14.

14.

Hashing It Out Over Cannabis: Moving Toward a Standard Guideline on Substance Use for Cardiac Transplantation Eligibility That Includes Marijuana.

Allen LA, Ambardekar AV.

Circ Heart Fail. 2016 Jul;9(7). pii: e003330. doi: 10.1161/CIRCHEARTFAILURE.116.003330. No abstract available.

15.

Evaluating Patient-Level Medication Regimen Complexity Over Time in Heart Transplant Recipients.

Bryant BM, Libby AM, Metz KR, Page RL 2nd, Ambardekar AV, Lindenfeld J, Aquilante CL.

Ann Pharmacother. 2016 Nov;50(11):926-934. doi: 10.1177/1060028016657552. Epub 2016 Jul 19.

PMID:
27371949
16.

CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients.

Deininger KM, Vu A, Page RL 2nd, Ambardekar AV, Lindenfeld J, Aquilante CL.

Clin Transplant. 2016 Sep;30(9):1074-81. doi: 10.1111/ctr.12790. Epub 2016 Jul 11.

PMID:
27314545
17.

Concomitant surgical cryoablation for refractory ventricular tachycardia and left ventricular assist device placement: a dual remedy but a recipe for thrombosis?

McIlvennan CK, Babu AN, Brieke A, Ambardekar AV.

J Cardiothorac Surg. 2016 Apr 11;11(1):53. doi: 10.1186/s13019-016-0451-x.

18.

High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.

Ambardekar AV, Forde-McLean RC, Kittleson MM, Stewart GC, Palardy M, Thibodeau JT, DeVore AD, Mountis MM, Cadaret L, Teuteberg JJ, Pamboukian SV, Cantor RS, Lindenfeld J.

J Heart Lung Transplant. 2016 Jun;35(6):722-30. doi: 10.1016/j.healun.2016.01.014. Epub 2016 Jan 18.

19.

Sex-related differences in age-associated downregulation of human ventricular myocardial β1-adrenergic receptors.

Lindenfeld J, Cleveland JC Jr, Kao DP, White M, Wichman S, Bristow JC, Peterson V, Rodegheri-Brito J, Korst A, Blain-Nelson P, Sederberg J, Hunt SA, Gilbert EM, Ambardekar AV, Minobe W, Port JD, Bristow MR.

J Heart Lung Transplant. 2016 Mar;35(3):352-361. doi: 10.1016/j.healun.2015.10.021. Epub 2015 Oct 19.

PMID:
26970472
20.

Patient-centered care for left ventricular assist device therapy: current challenges and future directions.

Breathett K, Allen LA, Ambardekar AV.

Curr Opin Cardiol. 2016 May;31(3):313-20. doi: 10.1097/HCO.0000000000000279. Review.

21.

Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study.

Ambardekar AV, Hunter KS, Babu AN, Tuder RM, Dodson RB, Lindenfeld J.

Circ Heart Fail. 2015 Sep;8(5):944-52. doi: 10.1161/CIRCHEARTFAILURE.114.001955. Epub 2015 Jul 1.

22.

Myocardial strain and strain rate from speckle-tracking echocardiography are unable to differentiate asymptomatic biopsy-proven cellular rejection in the first year after cardiac transplantation.

Ambardekar AV, Alluri N, Patel AC, Lindenfeld J, Dorosz JL.

J Am Soc Echocardiogr. 2015 Apr;28(4):478-85. doi: 10.1016/j.echo.2014.12.013. Epub 2015 Jan 23.

PMID:
25622999
23.

Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients.

McIlvennan CK, Page RL 2nd, Ambardekar AV, Brieke A, Lindenfeld J.

J Heart Lung Transplant. 2014 Dec;33(12):1312-4. doi: 10.1016/j.healun.2014.08.022. Epub 2014 Sep 16. No abstract available.

PMID:
25443872
24.

Clinical outcomes after continuous-flow left ventricular assist device: a systematic review.

McIlvennan CK, Magid KH, Ambardekar AV, Thompson JS, Matlock DD, Allen LA.

Circ Heart Fail. 2014 Nov;7(6):1003-13. doi: 10.1161/CIRCHEARTFAILURE.114.001391. Epub 2014 Oct 7. Review.

25.

Right ventricular systolic and diastolic function as assessed by speckle-tracking echocardiography improve with prolonged isolated left ventricular assist device support.

Herod JW, Ambardekar AV.

J Card Fail. 2014 Jul;20(7):498-505. doi: 10.1016/j.cardfail.2014.04.017. Epub 2014 Apr 28.

PMID:
24785158
26.

Clinical problem-solving. Missing elements of the history.

Allen LA, Ambardekar AV, Devaraj KM, Maleszewski JJ, Wolfel EE.

N Engl J Med. 2014 Feb 6;370(6):559-66. doi: 10.1056/NEJMcps1213196. No abstract available.

27.

Diff'rent strokes, different folks: advanced heart failure's changing outlook.

Allen LA, Ambardekar AV.

Circ Heart Fail. 2013 May;6(3):355-7. doi: 10.1161/CIRCHEARTFAILURE.113.000285. No abstract available.

28.

Preoperative evaluation and perioperative management of right ventricular failure after left ventricular assist device implantation.

Marzec LN, Ambardekar AV.

Semin Cardiothorac Vasc Anesth. 2013 Dec;17(4):249-61. doi: 10.1177/1089253213488246. Epub 2013 May 2. Review.

PMID:
23640105
29.

Left ventricular assist device effects on metabolic substrates in the failing heart.

Weitzel LB, Ambardekar AV, Brieke A, Cleveland JC, Serkova NJ, Wischmeyer PE, Lowes BD.

PLoS One. 2013;8(4):e60292. doi: 10.1371/journal.pone.0060292. Epub 2013 Apr 1.

30.

Longitudinal left ventricular structural and functional imaging during full support with continuous-flow ventricular assist devices: a retrospective, preliminary analysis.

Ambardekar AV, Dorosz JL, Cleveland JC Jr, Lindenfeld J, Buttrick PM.

J Heart Lung Transplant. 2012 Dec;31(12):1311-3. doi: 10.1016/j.healun.2012.09.004. Epub 2012 Oct 11. No abstract available.

PMID:
23063323
31.

Driving with a driveline: a survey of current practice patterns for allowing a patient supported with a left ventricular assist device to drive.

Ambardekar AV, Cannon AP, Cleveland JC Jr, Brieke A, Lindenfeld J.

J Heart Lung Transplant. 2011 Oct;30(10):1204-5. doi: 10.1016/j.healun.2011.06.002. Epub 2011 Jun 30. No abstract available.

PMID:
21723146
32.

Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support.

Ambardekar AV, Walker JS, Walker LA, Cleveland JC Jr, Lowes BD, Buttrick PM.

Circ Heart Fail. 2011 Jul;4(4):425-32. doi: 10.1161/CIRCHEARTFAILURE.111.961326. Epub 2011 May 3.

33.

Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).

Krantz MJ, Ambardekar AV, Kaltenbach L, Hernandez AF, Heidenreich PA, Fonarow GC; Get With the Guidelines Steering Committee and Hospitals.

Am J Cardiol. 2011 Jun 15;107(12):1818-23. doi: 10.1016/j.amjcard.2011.02.322. Epub 2011 Apr 12.

PMID:
21482418
34.

Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects.

Ambardekar AV, Buttrick PM.

Circ Heart Fail. 2011 Mar;4(2):224-33. doi: 10.1161/CIRCHEARTFAILURE.110.959684. Review. No abstract available.

35.

Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads.

Ambardekar AV, Lowery CM, Allen LA, Cannon AP, Cleveland JC Jr, Lindenfeld J, Brieke A, Sauer WH.

J Card Fail. 2010 Apr;16(4):327-31. doi: 10.1016/j.cardfail.2009.12.003. Epub 2010 Jan 8.

PMID:
20350700
36.

Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.

Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC Jr, Brieke A, Sauer WH.

J Heart Lung Transplant. 2010 Jul;29(7):771-6. doi: 10.1016/j.healun.2010.02.001. Epub 2010 Mar 29.

PMID:
20347337
37.

Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program).

Ambardekar AV, Fonarow GC, Dai D, Peterson ED, Hernandez AF, Cannon CP, Krantz MJ; Get With The Guidelines Steering Committee and Hospitals.

Am J Cardiol. 2010 Jan 15;105(2):139-43. doi: 10.1016/j.amjcard.2009.09.003. Epub 2009 Nov 14.

PMID:
20102907
38.

Medical images. Flip-flop heart.

Ambardekar AV, Krantz MJ.

Mayo Clin Proc. 2010 Jan;85(1):103. doi: 10.4065/mcp.2009.0627. No abstract available.

39.

Overdrive pacing suppresses ectopy and minimizes left ventricular assist device suction events.

Ambardekar AV, Lowes B, Cleveland JC Jr, Brieke A.

Circ Heart Fail. 2009 Sep;2(5):516-7. doi: 10.1161/CIRCHEARTFAILURE.109.881607. No abstract available.

40.

Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF).

Ambardekar AV, Fonarow GC, Hernandez AF, Pan W, Yancy CW, Krantz MJ; Get With the Guidelines Steering Committee and Hospitals.

Am Heart J. 2009 Oct;158(4):644-52. doi: 10.1016/j.ahj.2009.07.034.

PMID:
19781426
41.

Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies.

Peterson PN, Ambardekar AV, Jones PG, Krumholz HM, Schelbert E, Spertus JA, Rumsfeld JS, Masoudi FA.

BMC Cardiovasc Disord. 2009 Jul 8;9:29. doi: 10.1186/1471-2261-9-29.

42.

A structured handoff program for interns.

Chu ES, Reid M, Schulz T, Burden M, Mancini D, Ambardekar AV, Keniston A, Albert RK.

Acad Med. 2009 Mar;84(3):347-52. doi: 10.1097/ACM.0b013e3181970829.

PMID:
19240442
43.

The Brugada syndrome: the perfect storm of genetics and environment?

Ambardekar AV, Krantz MJ.

Int J Cardiol. 2010 May 14;141(1):108-9. doi: 10.1016/j.ijcard.2008.12.070. Epub 2009 Jan 21. No abstract available.

PMID:
19157599
44.

Case of ventricular noncompaction: the crypts and the blood.

Ambardekar AV, Krantz MJ.

Mayo Clin Proc. 2008 Aug;83(8):866. No abstract available.

PMID:
18674469
45.

Mastitis unmasks Brugada syndrome.

Ambardekar AV, Lewkowiez L, Krantz MJ.

Int J Cardiol. 2009 Mar 6;132(3):e94-6. Epub 2007 Nov 26.

PMID:
18036675
46.
47.

Evaluation of valvular regurgitation severity using digital acquisition of echocardiographic images.

Shah DJ, Diluzio S, Ambardekar AV, Smulevitz B, Smith GL, Nagaraj A, Hamilton AJ, McPherson DD, Rigolin VH.

J Am Soc Echocardiogr. 2002 Mar;15(3):241-6.

PMID:
11875387
49.

Supplemental Content

Loading ...
Support Center